Asian Pacific Journal of Cancer Prevention

  • 제15권6호
  • /
  • Pages.2511-2515
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Targeted Efficacy of Dihydroartemisinin for Translationally Controlled Protein Expression in a Lung Cancer Model

  • Liu, Lian-Ke (Department of Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Wu, Heng-Fang (Institute of Cardiovascular Disease, The First Affiliated Hospital of Nanjing Medical University) ;
  • Guo, Zhi-Rui (Institute of Cardiovascular Disease, The First Affiliated Hospital of Nanjing Medical University) ;
  • Chen, Xiang-Jian (Institute of Cardiovascular Disease, The First Affiliated Hospital of Nanjing Medical University) ;
  • Yang, Di (Institute of Cardiovascular Disease, The First Affiliated Hospital of Nanjing Medical University) ;
  • Shu, Yong-Qian (Department of Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Zhang, Ji-Nan (Institute of Cardiovascular Disease, The First Affiliated Hospital of Nanjing Medical University)
  • 발행 : 2014.03.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: Lung cancer is one of the malignant tumors with greatest morbidity and mortality around the world. The keys to targeted therapy are discovery of lung cancer biomarkers to facilitate improvement of survival and quality of life for the patients with lung cancer. Translationally controlled tumor protein (TCTP) is one of the most overexpressed proteins in human lung cancer cells by comparison to the normal cells, suggesting that it might be a good biomarker for lung cancer. Materials and Methods: In the present study, the targeted efficacy of dihydroartemisinin (DHA) on TCTP expression in the A549 lung cancer cell model was explored. Results and Conclusions: DHA could inhibit A549 lung cancer cell proliferation, and simultaneously up-regulate the expression of TCTP mRNA, but down-regulate its protein expression in A549 cells. In addition, it promoted TCTP protein secretion. Therefore, TCTP might be used as a potential biomarker and therapeutic target for non-small cell lung cancers.

키워드

참고문헌

  1. Acunzo J, Baylot V, So A2, et al (2014). TCTP as therapeutic target in cancers. Cancer Treat Rev, [Epub ahead of print].
  2. Al-Hashimi MM, Wang XJ. (2014). Trend analysis of lung cancer incidence rates in Ninawa province, Iraq, from 2000 to 2010--decrease and recent stability. Asian Pac J Cancer Prev, 15, 385-90. https://doi.org/10.7314/APJCP.2014.15.1.385
  3. Amson R, Pece S, Lespagnol A, et al (2011). Reciprocal repression between P53 and TCTP. Nat Med, 18, 91-9. https://doi.org/10.1038/nm.2546
  4. Amson R, Pece S, Marine JC, et al (2013). TPT1/TCTP-regulated pathways in phenotypic reprogramming. Trends Cell Biol, 23, 37-46. https://doi.org/10.1016/j.tcb.2012.10.002
  5. Baylot V, Katsogiannou M, Andrieu C, et al (2012). Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer. Mol Ther, 20, 2244-56. https://doi.org/10.1038/mt.2012.155
  6. Chen H, Sun B, Wang S, et al (2010). Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest andinactivation of nuclear factor-kappaB. J Cancer Res Clin Oncol, 136, 897-903. https://doi.org/10.1007/s00432-009-0731-0
  7. Chen T, Li M, Zhang R, et al (2009). Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy. J Cell Mol Med, 13, 1358-70. https://doi.org/10.1111/j.1582-4934.2008.00360.x
  8. Choi S, Min HJ, Kim M, et al (2009). Proton pump inhibitors exert anti-allergic effects by reducing TCTP secretion. PLOS One, 4, 478-96.
  9. Cui L, Liu XX, Jiang Y, et al (2014). Phase II study on dose escalating schedule of paclitaxel concurrent with radiotherapy in treating patients with locally advanced non-small cell lung cancer. Asian Pac J Cancer Prev, 15, 1699-702. https://doi.org/10.7314/APJCP.2014.15.4.1699
  10. Deng W, Long L, Li JL, et al (2014). Mortality of major cancers in guangxi, china: sex, age and geographical differences from 1971 and 2005. Asian Pac J Cancer Prev, 15, 1567-74. https://doi.org/10.7314/APJCP.2014.15.4.1567
  11. Dong X, Yang B, Li Y, et al (2009). Molecular basis of the acceleration of the GDP-GTP exchange of human ras homolog enriched in brain by human translationally controlled tumor protein. J Biol Chem, 284, 23754-64. https://doi.org/10.1074/jbc.M109.012823
  12. Fathallah RM, Dajani R (2013). Comparison of population based cancer incidence rates among Circassians, Chechans and Arabs in Jordan (1996-2005). Asian Pac J Cancer Prev, 14, 6035-40. https://doi.org/10.7314/APJCP.2013.14.10.6035
  13. Fujita T, Felix K, Pinkaew D, et al (2008). Human fortilin is a molecular target of dihydroartemisinin. FEBS Lett, 582, 1055-60. https://doi.org/10.1016/j.febslet.2008.02.055
  14. Handrick R, Ontikatze T, Bauer KD, et al (2010). Dihydroartemisinin induces apoptosis by a Bak-dependent intrinsic pathway. Mol Cancer Ther, 9, 2497-510. https://doi.org/10.1158/1535-7163.MCT-10-0051
  15. Huang XE, Tian GY, Cao J, et al (2013). Pemetrexed as a component of first-, second- and third- line chemotherapy in treating patients with metastatic lung adenocarcinoma. Asian Pac J Cancer Prev, 14, 6663-7. https://doi.org/10.7314/APJCP.2013.14.11.6663
  16. Jemal A, Bray F, Center MM et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  17. Jiao Y, Ge CM, Meng QH, et al (2007). Dihydroartemisinin is an inhibitor of ovarian cancer cell growth. Acta Pharmacol Sin, 28, 1045-56. https://doi.org/10.1111/j.1745-7254.2007.00612.x
  18. Kim JE, Koo KH, Kim YH, et al (2008). Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model. Exp Mol Med, 40, 709-20. https://doi.org/10.3858/emm.2008.40.6.709
  19. Keating GM (2012). Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria. Drugs, 72, 937-61. https://doi.org/10.2165/11203910-000000000-00000
  20. Lammers T, Kiessling F, Hennink WE, et al (2012). Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release, 161, 175-87. https://doi.org/10.1016/j.jconrel.2011.09.063
  21. Lee JH, Rho SB, Park SY, et al (2008). Interaction between fortilin and transforming growth factor-beta stimulated clone-22 (TSC-22) prevents apoptosis via the destabilization of TSC-22. FEBS Lett, 582, 1210-8. https://doi.org/10.1016/j.febslet.2008.01.066
  22. Liloglou T, Bediaga NG, Brown BR, et al (2014). Epigenetic biomarkers in lung cancer. Cancer Lett, 342, 200-12. https://doi.org/10.1016/j.canlet.2012.04.018
  23. Liu J, Yang XL, Li A, et al (2014). Epidemiological patterns of cancer incidence in southern china: based on 6 populationbased cancer registries. Asian Pac J Cancer Prev, 15, 1471-5. https://doi.org/10.7314/APJCP.2014.15.3.1471
  24. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods, 25, 402-8. https://doi.org/10.1006/meth.2001.1262
  25. Lo WY, Wang HJ, Chiu CW, et al (2012). miR-27b-regulated TCTP as a novel plasma biomarker for oral cancer: from quantitative proteomics to post-transcriptional study. J Proteomics, 77, 154-66. https://doi.org/10.1016/j.jprot.2012.07.039
  26. Lucibello M, Gambacurta A, Zonfrillo M, et al (2011). TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death. Exp Cell Res, 317, 2479-89. https://doi.org/10.1016/j.yexcr.2011.07.012
  27. Makridakis M, Vlahou A (2010). Secretome proteomics for discovery of cancer biomarkers. J Proteomics, 73, 2291-305. https://doi.org/10.1016/j.jprot.2010.07.001
  28. Miao X, Chen YB, Xu SL, et al (2013). TCTP overexpression is associated with the development and progression of glioma. Tumour Biol, 34, 3357-61. https://doi.org/10.1007/s13277-013-0906-9
  29. Molina JR, Adjei AA, Jett JR (2006). Advances in chemotherapy of non-small cell lung cancer. Chest, 130, 1211-9. https://doi.org/10.1378/chest.130.4.1211
  30. Mu D, Zhang W, Chu D, et al (2008). The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells. Cancer Chemother Pharmacol, 61, 639-45. https://doi.org/10.1007/s00280-007-0517-5
  31. Nagano-Ito M., Ichikawa S. (2012). Biological effects of Mammalian translationally controlled tumor protein (TCTP) on cell death, proliferation, and tumorigenesis. Biochem Res Int, 204960.
  32. Nam W, Tak J, Ryu JK et al (2007). Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. Head Neck, 29, 335-40. https://doi.org/10.1002/hed.20524
  33. Rasheed SA, Efferth T, Asangani IA, et al (2010). First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. Int J Cancer, 127, 1475-85. https://doi.org/10.1002/ijc.25315
  34. Sun Q, Teong B, Chen IF, et al (2014). Enhanced apoptotic effects of dihydroartemisinin-aggregated gelatin and hyaluronan nanoparticles on human lung cancer cells. J Biomed Mater Res B Appl Biomater, 102, 455-62. https://doi.org/10.1002/jbm.b.33023
  35. Susini L, Besse S, Duflaut D et al (2008). TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ, 15, 1211-20. https://doi.org/10.1038/cdd.2008.18
  36. Wang F, Hu C, Hua X, et al (2013). Translationally controlled tumor protein, a dual functional protein involved in the immune response of the silkworm, Bombyx mori. PLoS One, 8, e69284. https://doi.org/10.1371/journal.pone.0069284

피인용 문헌

  1. RNA interference-mediated knockdown of translationally controlled tumor protein induces apoptosis, and inhibits growth and invasion in glioma cells vol.12, pp.5, 2015, https://doi.org/10.3892/mmr.2015.4280
  2. vol.63, pp.1, 2015, https://doi.org/10.1002/bab.1335
  3. Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways vol.31, pp.5, 2016, https://doi.org/10.1002/jbmr.2771
  4. Serum translationally controlled tumor protein is involved in rat liver regeneration after hepatectomy vol.46, pp.13, 2016, https://doi.org/10.1111/hepr.12695
  5. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin vol.15, pp.1, 2017, https://doi.org/10.1186/s12964-017-0164-3